BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Why Has Utilization of Umbilical Cord Blood for Transplantation Declined?
cord blood transplant statistics | Why Has Utilization of Umbilical Cord Blood for Transplantation Declined?

Why Has Utilization of Umbilical Cord Blood for Transplantation Declined?

June 25, 2016 By Cade Hildreth (CEO) Leave a Comment

In recent years, the rate of umbilical cord blood utilization has declined. To understand the dynamics behind this change, you need to understand cord blood registries and cord blood transplant statistics. Data about umbilical cord blood transplants from the donor registry of the CW Bill Young Cell Transplantation Program, including the National Cord Blood Inventory, are reported annually.[1]

Discover class-defining bioproduction tools.

The program’s donor registry, also called the Be The Match Registry®, is operated under Federal contracts by the National Marrow Donor Program® (NMDP).

The Be The Match Registry® is the world’s largest hematopoietic cell registry, listing more than 10.5 million individuals and approximately 185,000 cord blood units.[2]

bitbio

Cord Blood Transplant Statistics | A Closer Look

In this article:

  • The National Marrow Donor Program
  • Bone Marrow Donors Worldwide
  • The Cooperation of NMDP and BMDW
  • The Decline in Utilization of Cord Blood for Transplantation Beginning in 2013
  • Why Has Umbilical Cord Blood Transplantation Declined?

The National Marrow Donor Program

The National Marrow Donor Program is a contractor for the CW Bill Young Cell Transplantation Program operated through the U. S. Department of Health and Human Services, Health Resources and Services Administration, and Healthcare Systems Bureau. It is a non-profit organization launched in Minneapolis, MN, USA, in 1986.

Pluristyx

Hematopoietic stem cell transplants from NMDP donors or umbilical cord blood units are used to treat patients with a variety of cancers and immune system conditions. To date, the NMDP had facilitated more than 55,000 transplants worldwide.[3]

Bone Marrow Donors Worldwide

Another group that exists is Bone Marrow Donors Worldwide (BMDW), an organization that coordinates the collection of the human leukocyte antigen (HLA) phenotypes of hematopoietic cell donors and cord blood units. BMDW participants currently include 48 cord blood banks from 32 countries worldwide.[4] Presently, more than 60,000 cord blood units are listed within its database.[5] This makes it the largest such database of its type in the world.

The Cooperation of NMDP and BMDW

The NMDP cooperates with BMDW in the Netherlands because BMDW coordinates communications between the world’s cord blood registries. Most national registries, including the NMDP’s Be The Match Registry®, have access to these worldwide volunteer donors, either through the BMDW or through individual terms and agreements.

iPSC-derived cardiomyocte therapy

Because of their wide reach, these organizations represent a method for assessing trends in cord blood banking storage and utilization, making them a valuable predictor of future trends. Specifically for this analysis, the CW Bill Young Cell Transplantation Program is used as a source of aggregated cord blood transplantation data.

Decline in Utilization of Cord Blood for Transplantation

Unfortunately, 2013 saw a decrease in the number of cord blood units used for transplant in the United States. In 2012, the CW Bill Young Cell Transplantation Program facilitated close to 1,200 transplants. In 2013, it facilitated approximately 1,100, a substantial year-over-year decline.[6]  See the image below.

umbilical cord transplant | Why Has Utilization of Umbilical Cord Blood for Transplantation Declined?

While the CW Bill Young Cell Transplantation Program did its last comprehensive analysis of registry data in 2014 using full-year 2013 data, it did release the following statement about FY 2014 data[7]:

“During 2014, cord blood units were used in 960 transplants. The National Cord Blood Inventory provided 544 cord blood units for these transplants.

Also, 1,225 transplants were performed using bone marrow and 4,068 transplants used peripheral blood stem cells.”

As mentioned previously, the registry facilitated close to 1,200 transplants in 2012, and approximately 1,100 in 2013.[8]  Therefore, 2014 again experienced a decline in cord blood utilization relative to the prior year, and peripheral blood stem cells again saw an increase in utilization. This information has been incorporated into the graph above.

From conversations with industry experts and independent analysis, BioInformant believes this trend is continuing.

However, this trend is primarily localized to the United States and Europe. Within the UK, the country’s National Health System (NHS) has been working toward building an established volume of publicly donated cord blood units to have as a national inventory for medical purposes. Furthermore, in other countries around the world, including the UK, China, Japan, Taiwan, and France, there have been increases in cord blood transplant rates compared to prior years.

Therefore, the growth or decline in cord blood transplant rates is a geographically dependent variable.

Why Has Cord Blood Transplantation Declined?

All of the information so far is interesting, but the important question here is, “Why has umbilical cord blood transplantation declined?”

The major reason for declining cord blood transplants in recent years is the increasing utilization of peripheral blood stem cells as an alternative for HSCT.

A much lesser reason is that there was declining utilization of bone marrow as a source of stem cells for HSCT from 1998 to 2005, but that trend corrected from 2005 to 2013, with the utilization of bone marrow slightly increasing over that period.

These answers are visually represented by the graph below.

bone marrow donors worldwide | Why Has Utilization of Umbilical Cord Blood for Transplantation Declined?

To learn more, view the “Global Cord Blood Banking Industry Report.“

What are your thoughts on cord blood transplant statistics and the decline in the utilization of umbilical cord blood for transplantation? Share them in the comments below.

Up Next: 38 Athletes Who Have Had Stem Cell Treatments

[1] “Donor Registry Transplant Data”. Home. [online]  Available at: Bloodcell.transplant.hrsa.gov. [Accessed 24 Apr. 2016].
[2] Bethematch.org. Home.  Available at: http://bethematch.org/ [Accessed 24 Apr. 2016].
[3] Ibid.
[4] Bmdw.org. BMDW: Home. Available at: http://bmdw.org/ [Accessed 25 Apr. 2016].
[5] Ibid.
[6]  “Donor Registry Transplant Data”. Registry Data. Available at: http://bloodcell.transplant.hrsa.gov/research/transplant_data/registry_tx_data/index.html. 2016. [Accessed 24 Apr. 2016].
[7]  “Blood Cell Transplantation”. Donor Registry Transplant Data. [online] Available at: http://bloodcell.transplant.hrsa.gov/ [Accessed 25 April 2016].
[8]  Bloodcell.transplant.hrsa.gov, (2014). Donor Registry Transplant Data. [online] Available at: http://bloodcell.transplant.hrsa.gov/research/transplant_data/registry_tx_data/index.html [Accessed 25 April 2016].

5/5 - (18 votes)

Filed Under: Cord Blood, HSCs, MSCs Tagged With: hematopoietic stem cells, HSCT, transplantation

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Tell Us What You Think! Cancel reply

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Featured Posts

Cord Blood Market Segmentation

Cord Blood Market Segmentation – Biobanking, HSCT, Cellular Therapy, Genetic Manipulation, & Research Tools

CAR-T Companies

CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide

Who discovered stem cells?

Who Discovered Stem Cells? The Answers Revealed

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.